Transcription Factor RelB
"Transcription Factor RelB" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transcription factor that takes part in the NF-kappa-B complex by interacting with NF-KAPPA B P50 SUBUNIT or NF-KAPPA B P52 SUBUNIT. It regulates GENETIC TRANSCRIPTION that is involved in immune and inflammatory responses.
| Descriptor ID |
D051841
|
| MeSH Number(s) |
D12.776.260.600.500 D12.776.660.600.500 D12.776.930.600.500
|
| Concept/Terms |
Transcription Factor RelB- Transcription Factor RelB
- RelB, Transcription Factor
- Rel-Related Protein
- Rel Related Protein
- v-Rel Reticuloendotheliosis Viral Oncogene Homolog B
- v Rel Reticuloendotheliosis Viral Oncogene Homolog B
- Inhibitory Rel Protein
- Rel Protein, Inhibitory
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factor RelB".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factor RelB".
This graph shows the total number of publications written about "Transcription Factor RelB" by people in this website by year, and whether "Transcription Factor RelB" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factor RelB" by people in Profiles.
-
Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases. J Neuroimmune Pharmacol. 2021 06; 16(2):403-424.
-
MyoD Regulates Skeletal Muscle Oxidative Metabolism Cooperatively with Alternative NF-?B. Cell Rep. 2016 10 04; 17(2):514-526.
-
Multifocal defects in immune responses in RelB-deficient mice. J Immunol. 1997 Jun 01; 158(11):5211-8.